HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
Provided By GlobeNewswire
Last update: Sep 18, 2025
Wugen closed a $115 million equity financing led by
Fidelity Management & Research Company
HCW Biologics holds a minority equity interest in Wugen
Read more at globenewswire.com
